Entry |
|
Name |
Fevipiprant (JAN/USAN/INN) |
Formula |
C19H17F3N2O4S
|
Exact mass |
426.0861
|
Mol weight |
426.41
|
Structure |

|
Efficacy |
Antiasthmatic, Anti-inflammatory, Prostaglandin D2 receptor antagonist |
Comment |
Treatment of asthma, allergic rhinitis
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostaglandin
PTGDR
D10631 Fevipiprant (JAN/USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 29
1 C8x C 13.1918 -16.6323
2 C8x C 13.1918 -18.0414
3 C8x C 14.3896 -18.7460
4 C8y C 15.6578 -18.0414
5 C8y C 15.6578 -16.6323
6 N5x N 14.3896 -15.9277
7 C8y C 16.9965 -18.4642
8 C8y C 17.7715 -17.3369
9 N4y N 16.9965 -16.2096
10 C1b C 17.3487 -14.8709
11 C8y C 18.6874 -14.4481
12 C8x C 19.6738 -15.4345
13 C8x C 21.0125 -15.0823
14 C8y C 21.4352 -13.7436
15 C8x C 20.4488 -12.7572
16 C8y C 19.0397 -13.1095
17 C1d C 18.0533 -12.1231
18 X F 18.4056 -10.7844
19 X F 17.0669 -11.1367
20 X F 16.7146 -12.4754
21 S4a S 22.7739 -13.3913
22 C1a C 24.1126 -12.9686
23 O3c O 22.4216 -11.9822
24 O3c O 23.1262 -14.7300
25 C1a C 19.1806 -17.3369
26 C1b C 17.3487 -19.8028
27 C6a C 18.6874 -20.2256
28 O6a O 19.8852 -19.5210
29 O6a O 19.0397 -21.5643
BOND 31
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 2
9 8 9 1
10 5 9 1
11 9 10 1
12 10 11 1
13 11 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 11 16 1
19 16 17 1
20 17 18 1
21 17 19 1
22 17 20 1
23 14 21 1
24 21 22 1
25 21 23 2
26 21 24 2
27 8 25 1
28 7 26 1
29 26 27 1
30 27 28 1
31 27 29 2
|